OPTI-OX
Live / Registered — Registered (as of 22 Jun 2021)
What this means for you
Registered since 22 Jun 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79293252
- Registration number
- 6391962
- Mark type
- Stylized text
- Filed
- 09 Jul 2020
- Published for opposition
- 06 Apr 2021
- Registered
- 22 Jun 2021
- Attorney of record
- Katrina G. Hull
Goods and services
- Class 001 — Chemicals: Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; skeletal myocytes for research purposes; cortical neurons for research purposes; biological human tissue for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media for scientific and research use; chemical reagents for use in biotechnology, other than for medical or veterinary use; nutritive agents for processing living cells other than for medical use; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology other than for medical use
- Class 005 — Pharmaceuticals: Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; genetically or otherwise modified cells for medical or clinical use; cells which are propagated, cultivated and expanded in bioreactors for medical or clinical use; cells for the purpose of tissue regeneration for medical or clinical use; living cells for medical use; cells for medical use; diagnostic preparations for medical and veterinary purposes; cell preparations for medical use in drug screening; cell preparations for genetic testing and screening for clinical and medical use; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells, tissue culture media, cytokines, antibodies and reagents for medical and diagnostic or clinical use; tissue culture media growth factors in the nature of cell growth, cell growth media and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells all for medical and clinical use; cell separation reagents for medical and clinical use; dietary supplements; protein supplements; nutrition supplements
- Class 009 — Scientific and electric apparatus: Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; downloadable and recorded bioinformatics software for collection of information on biological materials; downloadable and recorded software for the control of laboratory robots; downloadable and recorded software program for medical, clinical, research and biomanufacturing purposes, namely, downloadable and recorded software for conducting medical and clinical research and control laboratory biomanufacturing robots; bioreactors for biomanufacturing; bioreactors for research use; bioreactor for cell culturing; bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; laboratory apparatus for magnetic cell separation, namely, apparatus for the separation of cell populations for medical or clinical use; all the aforesaid goods excluding use for non-medical oxygen measurement
- Class 029 — Meats and processed foods: Meat; meat substitutes; tissue engineered meat; synthetic meat; cultured meat; laboratory-grown meat; fish, not live
- Class 040 — Treatment of materials: Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, stem cells for scientific purposes, stem cells other than for medical or veterinary purposes, skeletal myocytes for research purposes, cortical neurons for research purposes, biological tissue for research and scientific purposes, biological tissue cultures other than for medical or veterinary purposes, cultures of cell media other than for medical or veterinary use, chemical reagents for use in biotechnology, other than for medical or veterinary use, nutritive agents for processing living cells other than for medical use, semi-processed natural proteins for manufacturing food, proteins for use in the manufacture of food products, proteins for use in recombinant dna technology other than for medical use, cell therapeutics, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, living cells for medical use, cells for medical use, biological preparations for medical use, diagnostic preparations for medical and/or veterinary purposes, cell preparations for drug screening, cell preparations for genetic testing, screening, stem cells for medical purposes, stem cells for veterinary purposes, cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, cell separation reagents, magnetic cell separation equipment, dietary supplements, protein supplements, nutrition supplements, meat, meat substitutes, tissue engineered meat, synthetic meat, cultured meat, laboratory-grown meat and fish, not live
- Class 042 — Scientific and technological services: Biotechnology research; scientific testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; stem cell research; synthetic biology services, namely biological research; stem cell biology services, namely, biological research; scientific services for research, clinical, therapeutic and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells; research and development in relation to genetic testing, screening; research and development in relation to drug screening; cell separation technology services, namely, research of technology in the field of cell separation; cell separation research services; consultancy relating to biotechnology; scientific and research consultancy relating to drug screening for forensic research purposes; scientific and research consultancy relating to genetic screening; scientific and research consultancy relating to cell therapy; laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, synthetic biology and manufacturing; research on food; research and development in the field of animal cells cultivated within bioreactors; research in the reduction of carbon emissions; development and testing of computing methods, software algorithms and software for medical, clinical, research and biomanufacturing purposes
Owner
- Bit Bio Limited, GB
- Bit Bio Limited, GB
- Bit Bio Limited, GB
- Bit Bio Limited, GB
Prosecution history
- 08 Jan 2026 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 14 Feb 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 Nov 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 04 May 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 04 Nov 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 13 Oct 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 13 Oct 2021 — FINAL DISPOSITION PROCESSED
- 22 Sept 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 22 Jun 2021 — REGISTERED-PRINCIPAL REGISTER
- 06 Apr 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Apr 2021 — PUBLISHED FOR OPPOSITION
- 05 Apr 2021 — NOTIFICATION PROCESSED BY IB
- 18 Mar 2021 — CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 17 Mar 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 17 Mar 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB